[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 240, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 62, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 64, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 57, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erick J. Lucera C.F.A., CPA", "age": 57, "title": "CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Axel  Wiest", "title": "Senior VP and Head of Portfolio Strategy & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 59, "title": "Chief Technical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 53, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 59, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.25, "open": 15.05, "dayLow": 14.56, "dayHigh": 15.17, "regularMarketPreviousClose": 15.25, "regularMarketOpen": 15.05, "regularMarketDayLow": 14.56, "regularMarketDayHigh": 15.17, "payoutRatio": 0.0, "beta": 1.312, "forwardPE": -4.4821305, "volume": 1723015, "regularMarketVolume": 1723015, "averageVolume": 2464296, "averageVolume10days": 1678070, "averageDailyVolume10Day": 1678070, "bid": 14.84, "ask": 14.94, "bidSize": 1, "askSize": 2, "marketCap": 2450025472, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 25.0, "allTimeHigh": 47.45, "allTimeLow": 4.3, "fiftyDayAverage": 18.4615, "twoHundredDayAverage": 14.8596, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1453810304, "profitMargins": 0.0, "floatShares": 134205217, "sharesOutstanding": 164652236, "sharesShort": 19189031, "sharesShortPriorMonth": 17295386, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1165, "heldPercentInsiders": 0.0047299997, "heldPercentInstitutions": 1.12551, "shortRatio": 8.83, "shortPercentOfFloat": 0.12810001, "impliedSharesOutstanding": 164652236, "bookValue": 4.851, "priceToBook": 3.0674088, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -423800992, "trailingEps": -3.62, "forwardEps": -3.31985, "enterpriseToEbitda": -3.251, "52WeekChange": 0.12772131, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 14.88, "targetHighPrice": 60.0, "targetLowPrice": 16.0, "targetMeanPrice": 39.125, "targetMedianPrice": 39.5, "recommendationMean": 1.4375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 16, "totalCash": 791886976, "totalCashPerShare": 5.544, "ebitda": -447184992, "totalDebt": 120466000, "quickRatio": 13.231, "currentRatio": 13.472, "debtToEquity": 17.414, "returnOnAssets": -0.34320998, "returnOnEquity": -0.60659003, "freeCashflow": -242117632, "operatingCashflow": -375710016, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771629144, "regularMarketTime": 1771621203, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.42623, "regularMarketPrice": 14.88, "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "earningsTimestampStart": 1772139600, "earningsTimestampEnd": 1772139600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.62, "epsForward": -3.31985, "epsCurrentYear": -3.53095, "priceEpsCurrentYear": -4.2141633, "fiftyDayAverageChange": -3.5815, "fiftyDayAverageChangePercent": -0.19399832, "twoHundredDayAverageChange": 0.020400047, "twoHundredDayAverageChangePercent": 0.0013728531, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.4 - Strong Buy", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": 0.80645084, "postMarketPrice": 15.0, "postMarketChange": 0.119999886, "regularMarketChange": -0.37, "regularMarketDayRange": "14.56 - 15.17", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2464296, "fiftyTwoWeekLowChange": 8.52, "fiftyTwoWeekLowChangePercent": 1.3396227, "fiftyTwoWeekRange": "6.36 - 25.0", "fiftyTwoWeekHighChange": -10.12, "fiftyTwoWeekHighChangePercent": -0.4048, "fiftyTwoWeekChangePercent": 12.772131, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]